Is Epicardial Ablation a Cure for Brugada Syndrome?
At a Glance
Epicardial ablation effectively treats Brugada syndrome by neutralizing abnormal cells on the outside of the heart, reducing dangerous arrhythmias and ICD shocks. However, it is not a genetic cure. Patients still need an ICD and must continue avoiding triggers like fevers and specific medications.
In this answer
4 sections
Epicardial radiofrequency ablation is a specialized procedure that neutralizes the specific abnormal heart tissue causing Brugada syndrome arrhythmias [1]. While it can successfully normalize your electrocardiogram (ECG) and drastically reduce life-threatening arrhythmias (and prevent ICD shocks), it is not a genetic cure [2][3]. Because you still carry the underlying gene mutation for Brugada syndrome, you must continue to strictly manage triggers like fevers and avoid certain medications [4].
How the Procedure Works
In Brugada syndrome, the electrical misfires that cause dangerous heart rhythms typically originate from a specific cluster of abnormal cells. These cells are mostly located on the outside surface (epicardium) of the upper right area of the heart, known as the right ventricular outflow tract (RVOT) [5][6].
While many standard heart ablations involve threading a wire through a vein in the groin to the inside of the heart, an epicardial ablation is different. To reach the outside of the heart, an electrophysiologist (a heart rhythm specialist) typically inserts a specialized needle and catheter through the skin just below the breastbone [5].
Once in position, the catheter delivers targeted heat energy (radiofrequency) to safely destroy or “neutralize” these malfunctioning cells [5][7]. By eliminating this abnormal tissue (often referred to as the “arrhythmogenic substrate”), the heart’s electrical pathways are smoothed out, stopping the dangerous misfires that trigger events like ventricular fibrillation [1][8].
What Are the Results?
For many patients, the results are highly effective for managing symptoms:
- ECG Normalization: The signature “Type 1” Brugada pattern on the ECG often disappears entirely or normalizes after a successful ablation [2][9].
- Fewer ICD Shocks: The procedure drastically reduces the occurrence of ventricular arrhythmias, significantly cutting down the number of shocks patients receive from their implantable cardioverter-defibrillators (ICDs) [1][10].
- Storm Prevention: It is particularly beneficial for patients who have suffered from “electrical storms” (multiple severe arrhythmias in a short period) or those who cannot tolerate anti-arrhythmic medications like quinidine [11][12].
Risks and Recovery
Because this procedure accesses the space around the outside of the heart (the pericardial space), it carries specific risks and recovery considerations:
- Procedural Risks: Risks include bleeding around the heart (pericardial effusion) or, rarely, damage to the heart’s surface blood vessels [5].
- Post-Procedure Chest Pain: It is very common to experience chest pain for a few days after the procedure due to inflammation of the heart’s lining (pericarditis) [5]. Knowing this in advance can help prevent unnecessary panic, as it is a normal part of healing and not a sign of a heart attack.
- Hospital Stay: Most patients stay in the hospital for 1 to 2 days for monitoring and to manage any inflammatory chest pain with medication.
Why It Is Not a Complete “Cure”
Despite the dramatic improvements in symptoms and ECG readings, epicardial ablation is considered a highly effective management tool rather than a permanent cure.
- The Genetics Remain: The ablation neutralizes the most troublesome cells in the RVOT, but it does not change your DNA. The genetic mutation responsible for Brugada syndrome is still present in all of your cells [1][3].
- Potential for New Areas: Because the genetic vulnerability persists, it is possible for abnormal tissue to slowly develop or be unmasked in other parts of the heart over time [13][14].
- Ongoing Precautions: You must continue to follow all standard Brugada syndrome safety measures. You are still susceptible to triggers, meaning you must strictly treat fevers with fever-reducing medications (like acetaminophen), avoid extreme heat, and carefully avoid medications known to trigger Brugada arrhythmias [4][15].
- Continued ICD Use: While the ablation reduces the risk of sudden cardiac arrest, it does not completely eliminate it. Therefore, epicardial ablation is usually performed as an added layer of protection alongside an ICD, rather than replacing the device [16][17].
Common questions in this guide
Is epicardial ablation a permanent cure for Brugada syndrome?
How is an epicardial ablation performed?
Will I still need an ICD after my ablation?
What is recovery like after an epicardial ablation?
Why does the procedure target the right ventricular outflow tract (RVOT)?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Am I a good candidate for epicardial ablation based on my symptom history and ICD shock frequency?
- 2.How experienced is this medical center with epicardial ablation specifically for Brugada syndrome?
- 3.What are the specific risks associated with navigating a catheter to the outside (epicardium) of my heart?
- 4.How will we manage the typical post-procedure chest pain, and how will I know the difference between normal healing pain and an emergency?
- 5.If the ablation normalizes my ECG, will my ICD settings be adjusted?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (17)
- 1
Brugada Syndrome Ablation for the Prevention of Ventricular Fibrillation Episodes (BRAVE).
Nademanee K, Wongcharoen W, Chimparlee N, et al.
Heart rhythm 2025; (22(8)):1975-1983 doi:10.1016/j.hrthm.2025.04.033.
PMID: 40294736 - 2
Does Electrocardiographic Normalization Predict Successful Substrate Ablation in Brugada Syndrome?
Komatsu Y, Nogami A, Ieda M
Circulation journal : official journal of the Japanese Circulation Society 2021; (85(8)):1294-1295 doi:10.1253/circj.CJ-21-0237.
PMID: 33952836 - 3
Epicardial substrate ablation in patients with symptomatic Brugada syndrome: An updated systematic review and single-arm meta-analysis.
Karlinski Vizentin V, Ferreira Felix I, Pivato da Fonseca R, et al.
Heart rhythm 2025; (22(12)):3314-3322 doi:10.1016/j.hrthm.2025.01.006.
PMID: 39800093 - 4
[A man with fever-dependent ECG abnormalities].
de Jong Y, Bilsen M, Grauss RW
Nederlands tijdschrift voor geneeskunde 2019; (163()).
PMID: 30816649 - 5
Fibrosis, Connexin-43, and Conduction Abnormalities in the Brugada Syndrome.
Nademanee K, Raju H, de Noronha SV, et al.
Journal of the American College of Cardiology 2015; (66(18)):1976-1986 doi:10.1016/j.jacc.2015.08.862.
PMID: 26516000 - 6
Characterization of the epicardial substrate for catheter ablation of Brugada syndrome.
Zhang P, Tung R, Zhang Z, et al.
Heart rhythm 2016; (13(11)):2151-2158 doi:10.1016/j.hrthm.2016.07.025.
PMID: 27453126 - 7
Right ventricular electromechanical abnormalities in Brugada syndrome: is this a cardiomyopathy?
Pappone C, Monasky MM, Micaglio E, Ciconte G
European heart journal supplements : journal of the European Society of Cardiology 2020; (22(Suppl E)):E101-E104 doi:10.1093/eurheartj/suaa071.
PMID: 32523450 - 8
Role of Catheter Ablation for Ventricular Arrhythmias in Brugada Syndrome.
Chokesuwattanaskul R, Nademanee K
Current cardiology reports 2021; (23(5)):54 doi:10.1007/s11886-021-01479-2.
PMID: 33893882 - 9
Catheter Ablation for Brugada Syndrome.
Qin D, Bode WD, Heist EK, et al.
The Journal of innovations in cardiac rhythm management 2021; (12(5)):4520-4524 doi:10.19102/icrm.2021.120502.
PMID: 34035984 - 10
Catheter ablation in highly symptomatic Brugada patients: a Dutch case series.
Haanschoten DM, Elvan A, Postema PG, et al.
Clinical research in cardiology : official journal of the German Cardiac Society 2020; (109(5)):560-569 doi:10.1007/s00392-019-01540-9.
PMID: 31478073 - 11
Can Artemisinin Be a Game Changer Even as an Antiarrhythmic Drug?
Hwang J
Korean circulation journal 2023; (53(4)):251-253 doi:10.4070/kcj.2023.0031.
PMID: 37161683 - 12
Catheter Ablation vs. Standard Implantable Cardioverter Defibrillator Therapy in Symptomatic Brugada Syndrome: A Systematic Review and Meta-Analysis of Controlled Studies.
Karakasis P, Theofilis P, Pamporis K, et al.
Medical sciences (Basel, Switzerland) 2025; (13(3)) doi:10.3390/medsci13030115.
PMID: 40843736 - 13
Left Ventricular Abnormal Substrate in Brugada Syndrome.
Cheniti G, Haissaguerre M, Dina C, et al.
JACC. Clinical electrophysiology 2023; (9(10)):2041-2051 doi:10.1016/j.jacep.2023.05.039.
PMID: 37480873 - 14
Efficacy of Endocardial Ablation of Drug-Resistant Ventricular Fibrillation in Brugada Syndrome: Long-Term Outcome.
Talib AK, Takagi M, Shimane A, et al.
Circulation. Arrhythmia and electrophysiology 2018; (11(8)):e005631 doi:10.1161/CIRCEP.117.005631.
PMID: 30354308 - 15
Mechanism of the effects of sodium channel blockade on the arrhythmogenic substrate of Brugada syndrome.
Nademanee K, Veerakul G, Nogami A, et al.
Heart rhythm 2022; (19(3)):407-416 doi:10.1016/j.hrthm.2021.10.031.
PMID: 34742919 - 16
Epicardial ablation in high-risk Brugada syndrome to prevent ventricular fibrillation: results from a randomized clinical trial.
Pappone C, Ciconte G, Vicedomini G, et al.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2025; (27(5)) doi:10.1093/europace/euaf097.
PMID: 40401314 - 17
Catheter ablation as an adjunctive therapy to ICD implantation in Brugada Syndrome.
Doundoulakis I, Chiotis S, Pannone L, et al.
European heart journal. Quality of care & clinical outcomes 2024; (10(7)):590-601 doi:10.1093/ehjqcco/qcae040.
PMID: 38777620
This page explains epicardial ablation for Brugada syndrome for educational purposes only. Always consult your electrophysiologist to determine the safest and most appropriate treatment plan for your specific heart condition.
Get notified when new evidence is published on Brugada syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.